Latest news
Loading news…
Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.
Vedere Bio ll was acquired by Novartis in 2020 for $280M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
11
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Cambridge, Massachusetts, United States
Key People at Vedere Bio ll
Chief Financial Officer
SVP Strategy & Program Leadership
11
professional contacts at Vedere Bio ll
Contact execs at Vedere Bio ll →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Vedere Bio ll
Loading news…
FAQs about Vedere Bio ll
People who checked this page also checked these
Browse the full Acquirezy directory.